Literature DB >> 443916

An interim report on parietal cell vagotomy versus selective vagotomy and antrectomy for treatment of duodenal ulcer.

P H Jordan.   

Abstract

This is an interim report of a prospective, randomized study involving 194 consecutive patients who underwent elective operation for treatment of duodenal ulcer. The results of parietal cell vagotomy without drainage (PCV) and selective vagotomy-antrectomy and Billroth I anastomosis (SV-A-B I) were compared. There was no mortality. Postoperatively patients were examined at two, six, 12 months and every 12 months thereafter. The two operations showed no statistical difference in the frequency of diarrhea. Dumping was less (p < .01) after PCV than after SV-A-B I. Weight loss was less (p < .01) after PCV than after SV-A-B I. There were no recurrent ulcers after SV-A-B I and five after PCV. In each instance but one the recurrent ulcer healed on withdrawal of an ulcerogenic drug. One patient required reoperation. Reoperations in the PCV group consisted of one for recurrent ulcer, one for gastric outlet obstruction and three for intestinal obstruction. The reoperations after SV-A-B I consisted of four for gastric outlet obstruction, three for intestinal obstruction, one for ruptured spleen and two for incisional hernia. PCV was technically feasible and practical to perform except in the occasional patient with severe pyloric stenosis. Obesity was never a deterrent. After PCV it is reasonable to assume that a recurrent ulcer rate in the range of 5-10% can be expected by surgeons who have been properly trained. This recurrence rate is higher than that after SV-A-B I but no higher than that encountered with TV-P. The recurrence rate is acceptable and is a fair exchange for the avoidance of dumping and weight loss that accompany SV-A-B I with significantly greater frequency and which on occasion can produce gastric crippling, although this did not occur in this study. All recurrent ulcers after PCV do not require reoperation but when operative treatment is required the patient has all the options that he had prior to PCV.

Entities:  

Mesh:

Year:  1979        PMID: 443916      PMCID: PMC1397174          DOI: 10.1097/00000658-197905000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  33 in total

1.  Proximal gastric vagotomy compared with vagotomy and antrectomy and selective gastric vagotomy and pyloroplasty.

Authors:  J L Sawyers; J L Herrington; D P Burney
Journal:  Ann Surg       Date:  1977-10       Impact factor: 12.969

2.  The Aarhus County vagotomy trial. I. An interim report on primary results and incidence of sequelae following parietal cell vagotomy and selective gastric vagotomy in 748 patients.

Authors:  E Amdrup; D Andersen; H Høstrup
Journal:  World J Surg       Date:  1978-01       Impact factor: 3.352

Review 3.  Current status of parietal cell vagotomy.

Authors:  P H Jordan
Journal:  Ann Surg       Date:  1976-12       Impact factor: 12.969

4.  Follow-up of 100 patients five to eight years after parietal cell vagotomy.

Authors:  H E Jensen; E Amdrup
Journal:  World J Surg       Date:  1978-07       Impact factor: 3.352

5.  Proximal gastric vagotomy without drainage for duodenal ulcer: results after 5-8 years.

Authors:  J C Goligher; G L Hill; T E Kenny; E Nutter
Journal:  Br J Surg       Date:  1978-03       Impact factor: 6.939

6.  The Aarhus County vagotomy trial. II. An interim report on reduction in acid secretion and ulcer recurrence rate following parietal cell vagotomy and selective gastric vagotomy.

Authors:  D Andersen; H Høstrup; E Amdrup
Journal:  World J Surg       Date:  1978-01       Impact factor: 3.352

7.  Effect of selective proximal vagotomy and truncal vagotomy on gastric acid and serum gastrin responses to a meal in duodenal ulcer patients.

Authors:  J C Thompson; W S Lowder; J T Peurifoy; J S Swierczek; P L Rayford
Journal:  Ann Surg       Date:  1978-10       Impact factor: 12.969

8.  Prospective randomized multicentre trial of proximal gastric vagotomy or truncal vagotomy and antrectomy for chronic duodenal ulcer: interim results.

Authors:  N J Dorricott; A R Mcneish; J Alexander-Williams; C M Royston; W M Cooke; C J Spencer; B C De Vries; H Muller
Journal:  Br J Surg       Date:  1978-03       Impact factor: 6.939

9.  Effect of truncal vagotomy on gastroduodenal content of gastrin.

Authors:  J Malmstrom; F Stadil; K C Christensen
Journal:  Br J Surg       Date:  1977-01       Impact factor: 6.939

10.  Our first 35 patients studied five years after parietal cell vagotomy.

Authors:  P H Jordan
Journal:  Arch Surg       Date:  1979-04
View more
  9 in total

1.  Recurrent peptic ulcers.

Authors:  D Johnston; R L Blackett
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

Review 2.  Recent advances in the treatment of duodenal ulcer disease. A surgical perspective.

Authors:  M W Mulholland; H T Debas
Journal:  West J Med       Date:  1987-09

3.  Proximal gastric vagotomy after five years.

Authors:  D W Storey; P B Boulos; M W Ward; C G Clark
Journal:  Gut       Date:  1981-09       Impact factor: 23.059

4.  Peptic ulcer disease: the flowers that bloom in the spring.

Authors: 
Journal:  West J Med       Date:  1981-09

5.  Parietal cell vagotomy: experience with 114 patients with prepyloric or duodenal ulcer.

Authors:  J W Hollinshead; R C Smith; D J Gillett
Journal:  World J Surg       Date:  1982-09       Impact factor: 3.352

6.  Endoscopic management of peptic ulcer disease.

Authors:  H L Laws; J B McKernan
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

7.  Should it be parietal cell vagotomy or selective vagotomy-antrectomy for treatment of duodenal ulcer? A progress report.

Authors:  P H Jordan; J Thornby
Journal:  Ann Surg       Date:  1987-05       Impact factor: 12.969

8.  Indications for parietal cell vagotomy without drainage in gastrointestinal surgery.

Authors:  P H Jordan
Journal:  Ann Surg       Date:  1989-07       Impact factor: 12.969

Review 9.  Current status of proximal gastric vagotomy.

Authors:  B D Schirmer
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.